(MedPage Today) — Women with nonmalignant uterine disease and a history of GLP-1 agonist and progestin treatment had a significantly lower risk of endometrial cancer (EC) compared with progestins alone, a retrospective study showed.
Based on…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/119849
Author :
Publish date : 2026-02-11 22:32:00
Copyright for syndicated content belongs to the linked Source.
